1-naphthylamine has been researched along with Atrial Fibrillation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Antzelevitch, C; Barajas-Martinez, H; Burashnikov, A; Grunnet, M; Hu, D; Robinson, VM | 1 |
| Aflaki, M; Brundel, BJ; Diness, JG; Dobrev, D; Grunnet, M; Harada, M; Huang, H; Nattel, S; Naud, P; Qi, XY; Wu, CT; Zhou, XB | 1 |
| Bentzen, BH; Christ, T; Diness, JG; Grunnet, M; Jespersen, T; Kappert, U; Matschke, K; Poulet, C; Ravens, U; Skibsbye, L; Wettwer, E; Yuan, L | 1 |
| Buhl, R; Carstensen, H; Diness, JG; Flethøj, M; Grunnet, M; Haugaard, MM; Hesselkilde, EZ; Jespersen, T; Pehrson, S; Præstegaard, KF; Sørensen, US | 1 |
| Al-Shahib, B; Diness, JG; Grunnet, M; Hansen, RS; Jespersen, T; Nissen, JD; Sørensen, US | 1 |
| Diness, JG; Grunnet, M; Hansen, RS; Skibsbye, L; Sørensen, US | 1 |
| Bartels, ED; Diness, JG; Grunnet, M; Hansen, RS; Jespersen, T; Skibsbye, L; Sørensen, US | 1 |
7 other study(ies) available for 1-naphthylamine and Atrial Fibrillation
| Article | Year |
|---|---|
The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
Topics: 1-Naphthylamine; Action Potentials; Alkanes; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Female; Heart Atria; Heart Rate; Heart Ventricles; HEK293 Cells; Humans; Male; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quinolinium Compounds; Refractory Period, Electrophysiological; Small-Conductance Calcium-Activated Potassium Channels; Sodium Channel Blockers | 2020 |
Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog.
Topics: 1-Naphthylamine; Animals; Atrial Fibrillation; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Electrophysiological Phenomena; Heart Atria; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channel Blockers; Pulmonary Veins; Small-Conductance Calcium-Activated Potassium Channels | 2014 |
Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria.
Topics: 1-Naphthylamine; Action Potentials; Atrial Fibrillation; Heart Atria; Heart Ventricles; Humans; Membrane Potentials; Myocardium; Myocytes, Cardiac; Pyridines; RNA, Messenger; Small-Conductance Calcium-Activated Potassium Channels; Thiazoles | 2014 |
Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.
Topics: 1-Naphthylamine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Heart Atria; Horses; Immunohistochemistry; Microscopy, Confocal; Models, Anatomic; Myocytes, Cardiac; Small-Conductance Calcium-Activated Potassium Channels; Treatment Outcome | 2015 |
Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.
Topics: 1-Naphthylamine; Acetylcholine; Action Potentials; Alkanes; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Electrocardiography; Female; Guinea Pigs; In Vitro Techniques; Male; Myocardium; Perfusion; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Pyridines; Quinolinium Compounds; Rabbits; Rats; Rats, Sprague-Dawley; Thiazoles; Time Factors | 2010 |
The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels.
Topics: 1-Naphthylamine; Alkanes; Anesthesia; Animals; Anti-Arrhythmia Agents; Apamin; Atrial Fibrillation; Cardiac Pacing, Artificial; Disease Models, Animal; Dose-Response Relationship, Drug; Insect Proteins; Male; Molecular Targeted Therapy; Potassium Channel Blockers; Quinolinium Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Reaction Time; Small-Conductance Calcium-Activated Potassium Channels; Time Factors | 2011 |
Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition.
Topics: 1-Naphthylamine; Age Factors; Alkanes; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Disease Models, Animal; Humans; Hypertension; Injections, Intravenous; Male; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Quinolinium Compounds; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity; Time Factors | 2011 |